I have no idea what you're talking about. There were medical papers published out of SK in February indicating preliminary signs that some drugs were worth inve

I have no idea what you're talking about. There were medical papers published out of SK in February indicating preliminary signs that some drugs were worth investigating. The investigations happened. The results were published. If you were sitting through that process feeling like you knew which way it was going to go one way or the other based upon political tweets then you'd describe it as "snake oil" as the author did, when in fact it was just the normal, albeit accelerated, clinical research process with a lot of noise from the bleachers. My own assessment is any scenarios where preliminary data was less than ideal (eg due to non-randomization) was published in the interest of sharing information due to the urgency of the crisis to help guide further controlled trial development. And look, it worked, most of the drugs who had early papers published with clinical patient data pointing in a positive direction did in fact get into trials. Unfortunately so far there have been no home runs but some solid base hits. The reality is that most of these kinds of things like using the term "snake oil" to describe HCQ are an obvious "tell" on the part of people who consider themselves immune to cognitive dissonance and confirmation bias to be anything but.